CD56(+bright) and CD56(+dim) natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis

Bryce A. Pierson, Jeffrey S. Miller

Research output: Contribution to journal › Article › peer-review

123 Scopus citations

Fingerprint

Dive into the research topics of 'CD56(+bright) and CD56(+dim) natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences